Quantifying the Importance of Interleukin-6 for Coronary Heart Disease

1. CantoJIskandrianA

2003

Major risk factors for cardiovascular disease: Debunking the “only 50%” myth.

JAMA

290

947

949

2. HanssonG

2005

Inflammation, atherosclerosis and coronary artery disease.

N Engl J Med

352

1685

1695

3. MacMahonSPetoRCutlerJCollinsRSorlieP

1990

Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias.

Lancet

335

765

774

4. DaneshJKaptogeSMannAGSarwarNWoodA

2008

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review.

PLoS Med

5

e78

doi:10.1371/journal.pmed.0050078

5. RosnerBSpiegelmanDWillettW

1992

Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error.

Am J Epidemiol

136

1400

1413

6. FrostCThompsonS

2000

Correcting for regression dilution bias: Comparison of methods for a single predictor variable.

J R Stat Soc [Ser A]

163

173

190

7. World Health Organization

2002

World Health Report 2002; Reducing risks, promoting healthy life.

Available: http://www.who.int/whr/2002/en/. Accessed 4 March 2008

8. YusufSHawkenSÔunpuuSDansTAvezumA

2004

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countires (the INTERHEART Study): Case control study.

Lancet

364

937

952

9. JamisonDTBremanJGMeashamARAlleyneGClaesonM

editors

(2006) Disease control priorities in developing countries.

Available: http://www.dcp2.org/pubs/DCP. Accessed 4 March 2008

10. MurrayCLauerJHutubessyRNiessenLTomijimaN

2003

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk.

Lancet

361

717

725